Vanderbilt recruiting up to 1,000 for COVID-19 vaccine trial

NASHVILLE, Tenn. (AP) — Vanderbilt University Medical Center is looking for up to 1,000 volunteers to participate in the late-stage trial of an experimental COVID-19 vaccine.

The hospital says it will begin recruiting people at the end of the month. The vaccine is being developed by Moderna Inc. with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.

The randomized, placebo-controlled phase 3 trial will be open to people 18 or older. They will receive two shots of either the vaccine or an inactive placebo and will be followed for two years.

The trial aims to determine how effective the vaccine is in protecting against COVID-19 and how long the protection lasts.

Officials say several U.S. centers are participating in the nationwide phase 3 trial, which will enroll 30,000 volunteers over the next two months.

Those interested can contact Vanderbilt University Medical Center at covidvaccine@vumc.org or vaccineresearch@vumc.org.

Best Of

the best

1/25

Subscribe to Our Newsletter

Contact Us

Southern Standard • We Are MT

(931) 473-2191

105 College Street

McMinnville, TN 37110

  • White Facebook Icon